The company said on April 1, 2025 that it had appointed Stephen Williamson, 58, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., as an independent director and member of the Audit Committee. The appointment is effective as of April 1, 2025.

1. 01

   The company said on April 1, 2025 that it had appointed Stephen Williamson, 58, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., as an independent director and member of the Audit Committee. The appointment is effective as of April 1, 2025.

2. 02

   The company said Mr. Williamson will stand for election at the 2025 Annual Meeting of Shareowners and will receive compensation as a non-employee director under the company's previously disclosed non-employee director compensation practices.

3. 03

   The company said Mr. Williamson was named Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific in August 2015, where he oversees finance, tax, M&A, treasury and global business services, and that previously he held finance roles at Honeywell, including Vice President and Chief Financial Officer, Asia Pacific.

4. 04

   The company said Vimal Kapur, Chairman and Chief Executive Officer, stated that Mr. Williamson brings extensive financial expertise and significant international business experience, and that his M&A experience will be invaluable to Honeywell as it pursues its transformational objectives.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.